why choose us

First received: May 10, 2023

Clinical Trial: First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Advanced Solid Tumor

Study Type: INTERVENTIONAL


Official Title: Phase 1/2, Open-label, Multicenter, First-in-Human Study of DS-3939a in Subjects With Advanced Solid Tumors

Brief Summary: This study will evaluate the safety, tolerability, and efficacy of DS-3939a in participants with advanced solid tumors.

Read more